IP Library › Granted Patent US 9,095,558
Granted Patent B2
US 9,095,558 · App. 13/269,344 · Granted Aug 4, 2015

Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications

Inventors: Sarah Mayes (Austin, TX); Christine E. Schmidt (Austin, TX)
Assignee: Board of Regents, The University of Texas System
A61K31/192A61K31/195A61L31/041A61L31/145
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,558
App. No.
13/269,344
Granted
Aug 4, 2015
Kind
B2
Abstract

A non-synthetic, hydrophilic, biodegradable, biocompatible polysaccharide based non-toxic anti-adhesion hydrogel barrier is disclosed herein. The barrier of the present invention is formed by constructing a unique interpenetrating, crosslinked network with a unique porosity. Furthermore, the barrier of the present invention is comprised of tunable biopolymers for controllable mechanical robustness and degradation. The barrier of the present invention effectively reduces unwanted adhesions using non-synthetic components.

Claims (16)

1. An apparatus comprising:

a dessicated, amorphous, translucent, flexible, hydrogel film including:

a first film layer comprising uncrosslinked hyaluronic acid and alginate that is negatively charged and crosslinked with at least one calcium cation; and

a second film layer comprising uncrosslinked hyaluronic acid and alginate that is negatively charged and crosslinked with at least one calcium cation;

wherein (a) the first film layer is fused to the second film layer; and (b) the first film layer is anti-adhesive and non-attractive to cells and the second film layer is adhesive to cells.

2. The apparatus of claim 1 , wherein the hyaluronic acid and alginate in the first layer are formed around a pore network.

3. The apparatus of claim 2 , wherein the pore network is branched.

4. The apparatus of claim 1 , wherein the hydrogel film is bonded to a surface coating via one or more bonds comprising ester bonds, carboxylate bonds, carbonyl bonds, ether bonds, imide bonds, and combinations thereof.

5. The apparatus of claim 1 wherein the hydrogel film is configured to prevent tissue adhesion following surgery.

6. The apparatus of claim 1 , wherein the hydrogel film is non-cytotoxic.

7. The apparatus of claim 1 , wherein the hydrogel film encapsulates at least one of a drug, growth factor, hormone, protein, and combinations thereof.

8. The apparatus of claim 1 , wherein the hydrogel film is unpatterned.

9. The apparatus of claim 1 comprising hyaluronic acid crosslinked to an outer surface of the hydrogel film.

10. The apparatus of claim 1 comprising:

wherein the second layer includes channels comprising at least one of a drug, growth factor, hormone, protein, and combinations thereof.

11. The apparatus of claim 1 comprising at least 1% and no more than 33% composition hyaluronic acid.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jun 15, 2016
From: UNIVERSITY OF TEXAS, AUSTIN
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 039024/0536 →
CONFIRMATORY LICENSE Recorded May 13, 2015
From: UNIVERSITY OF TEXAS, AUSTIN
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 035652/0553 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2013
From: PETERSON, DANIEL
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 030944/0235 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2012
From: MAYES, SARAH; SCHMIDT, CHRISTINE E.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 027537/0031 →
Continuity (2)
Provisional Application 61391299 · Oct 8, 2010
Related Publication 20120088832A1 · Apr 12, 2012